Skip to main content

Clinical Cardiology

RSS  

Articles

  • ICDs and Hospice

    The authors sent a survey questionnaire to almost 800 hospices. Responses were obtained from 414. The survey asked an administrator whether or not their facility had admitted patients with active ICDs, whether any of these patients had been shocked in the past year, and whether any patient had received multiple shocks.
  • Pharmacology Watch

    FDA is reviewing safety of TZDs; SSRI use with tamoxifen; Metformin smells like fish; FDA Actions.
  • Cardiac Surgery in Nonagenarians

    Cardiac surgery carries greater risk in older patients. Nonagenarians are a growing part of cardiology practice as our population ages.
  • Clinical Briefs in Primary Care Supplement

  • Pharmacology Watch

    Two oral medications for relapsing-remitting MS in phase III development; antihypertensives find new uses; Ginkgo biloba does not prevent cognitive decline in elderly; and FDA Actions.
  • PCI versus CABG in Diabetics

    Coronary artery bypass surgery (CABG) has long been the preferred revascularization strategy for diabetic patients, but recent advances in technology have resulted in improved outcomes following percutaneous coronary intervention (PCI).
  • Stress Cardiomyopathy

    Stress-induced apical cardiomyopathy (Tako-Tsubo) is a recently recognized reversible form of acute cardiomyopathy that may mimic acute myocardial infarction initially.
  • Ablation vs. Drugs for Paroxysmal Atrial Fibrillation

    Catheter ablation for atrial fibrillation (AF) was first proposed over fifteen years ago but, until recently, there have been no FDA-approved devices specifically labeled for the treatment of AF.
  • Update on VT Ablation

    This paper details mortality results after ventricular tachycardia (VT) ablation from one of the larger VT ablation sites in the United States, the University of Pennsylvania.
  • A Signal From JUPITER

    Statins are now well established as powerful and favorable lipid-modifying drugs. They are primarily used for individuals with coronary artery disease or an abnormal lipid panel, and result in major decreases in morbidity and mortality.